We use essential cookies and third-party cookies for content.

Arizona Tribune - Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results

Arizona Tribune
×
NYSE - LSE
RBGPF 0% 61.3 $
CMSC -0.09% 22.046 $
GSK 1.54% 51.89 $
NGG 0.71% 83.42 $
BTI 1.74% 62.48 $
BCE 0% 23.2 $
CMSD -0.41% 21.93 $
RIO 1.14% 95.11 $
RYCEF -0.89% 18 $
BP -0.37% 37.72 $
RELX -0.74% 30.92 $
BCC 2.63% 79.76 $
AZN 1.43% 185.68 $
JRI 0.08% 12.58 $
VOD 0.36% 13.86 $
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results

Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results

BOULEVARD 29.04.2025

LOS GATOS, CA / ACCESS Newswire / April 29, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the first quarter 2025 ended March 31, 2025 after market close on Tuesday, May 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

Text size:

Date:

Tuesday, May 13, 2025

Time:

4:30 p.m. Eastern time

Dial-in:

1-877-407-0792

International Dial-in:

1-201-689-8263

Webcast:

TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through May 28, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13752970.

About Tenon Medical, Inc.

Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit www.tenonmed.com.

The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.

Investor Contact

Shannon Devine
MZ North America
203-741-8811
[email protected]

SOURCE: Tenon Medical, Inc.



View the original press release on ACCESS Newswire

H.Romero--AT

Featured

Quake-hit Venezuela's hospitals care for children left alone

Quake-hit Venezuela's hospitals care for children left alone
Venezuela mounts desperate search for survivors after twin quakes kill at least 188

Venezuela mounts desperate search for survivors after twin quakes kill at least 188
Venezuelans trapped alive after twin quakes kill at least 188

Venezuelans trapped alive after twin quakes kill at least 188
US Supreme Court hands win to Bayer in weedkiller litigation

US Supreme Court hands win to Bayer in weedkiller litigation